Iaso is a vaccine research and development company based on a new carrier protein mutant Qbeta. A wide range of antigens can be conjugated to the mQbeta including peptide, proteins, and sugars.
Iaso is a vaccine research and development company based on a new carrier protein mutant Qbeta. A wide range of antigens can be conjugated to the mQbeta including peptide, proteins, and sugars.